5-Arylidene derivatives of 3-(benzo[d]thiazol-2-ylamino)-2-thioxothiazolidin-4-one as potential antineoplastic agents – in silico evaluation

Mosula, L.M. and Zhmura, I.O. and Mosula, V.S. (2025) 5-Arylidene derivatives of 3-(benzo[d]thiazol-2-ylamino)-2-thioxothiazolidin-4-one as potential antineoplastic agents – in silico evaluation. Медичні перспективи, 30 (3). pp. 211-219. ISSN 2307-0404, online 2786-4804

Text 5-Arylidene derivatives of 3-(benzo[d]thiazol-2-ylamino)-2-thioxothiazolidin-4-one.pdf Download (486kB)

Abstract

Computer modeling and in silico prediction of molecular properties are rational approaches in early Drug Development, facilitating the targeted synthesis. One of the promising scaffold for the Drug Design is the rhodanine cycle due to the possibility of introducing substituents in positions 3 and 5. The aim of the work is to study the spectrum of biological activity of a series of 5-arylidene derivatives of 3-(benzo[d]thiazol-2-ylamino)-2 thioxothiazolidin-4-one, predict the affinity for therapeutic targets and establish their possible affiliation to certain codes according to the Anatomical Therapeutic Chemical Classification System of drugs, and predict possible toxicity of hit compounds via the online services. The investigated series of compounds consists of 21 derivatives. In silico prediction was carried out with the use of the web resources SuperPred 3.0, ProTox 3.0. A wide spectrum of biological activity of the derivatives of the series with a predominant antitumour effect is demonstrated. The group structural similarity of compounds to antineoplastic and immunomodulating agents was established. A high probability of group-level efficacy is predicted for the antitumor therapy targets: Krüppel-like factor 5, Nuclear factor erythroid 2-related factor 2, and DNA-(apurinic/apyrimidinic site) lyase. Compounds 3 ((ethyl (E)-4-(2-(2-((3-(benzo[d]thiazol-2-ylamino)-4- oxo-2-thioxothiazolidin-5-ylidene)methyl)-4-chlorophenoxy)acetamido)benzoate)), 4 ((E)-2-(2-((3-(benzo[d]thiazol-2-ylamino)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)-4-chlorophenoxy)-N-(4 sulfamoylphenyl)acetamide) and 9 ((E)-2-(2-((3- (benzo[d]thiazol-2-ylamino)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)-4,6-dimethylphenoxy)acetamide) can be considered as hit compounds. With high predictive model accuracy, their potential impact on the specified targets is 99.43%, 95.88%, and 96.92%, respectively. Compound 3 is a potential multi-hitter. The obtained results confirmed the viability of further in vitro, in vivo research.

Item Type:	Article
Additional Information:	DOI:10.26641/2307-0404.2025.3.340765 https://medpers.dmu.edu.ua/uk/2025-tom-xxx/no-3#pdf-22
Uncontrolled Keywords:	rhodanine, benzothiazole, 5-arylidene substituents, biological activity, drug development, in silico prediction, antineoplastic agents, SAR analysis
Subjects:	Pharmacy
Divisions:	University periodicals > Medical perspectives
Depositing User:	Аліна Чеботарьова
Date Deposited:	22 Apr 2026 12:18
Last Modified:	22 Apr 2026 12:18
URI:	http://repo.dma.dp.ua/id/eprint/9884

Actions (login required)

View Item